• Monday 02 July 2018
  • 09:00
    Plenary session: Translational mycology / From laboratory discovery to patient care

    Don Sheppard, Canada
  • 10:00
    Break
  • 10:30
    Parallel session IV

    Parallel session IV will take place from 10:30 hrs. until 12:00 hrs. and consists of six symposia.
  • S4.1 Molecular and cell biology of fungal pathogens

    Convener: Neil Gow, United Kingdom
    • 10:30
      S4.1a The cell biology of cell walls of fungal pathogens and the interaction with immune cells

      Neil Gow, United Kingdom
    • 10:55
      S4.1b Cell biology and structure of the Candida cell wall

      Megan Lenardon
    • 11:20
      S4.1c Haploid Candida albicans as a powerful tool for new discoveries

      Yue Wang, Singapore
    • 11:45
      S4.1d selected abstracts
  • S4.2 Cryptococcal meningitis clinical trials

    Convener: Tihana Bicanic, United Kingdom
    • 10:30
      S4.2a ACTA and beyond

      Tom Harrison, United Kingdom
    • 10:55
      S4.2b New and novel agents for prevention of cryptococcal disease

      David Boulware, USA
    • 11:20
      S4.2c AmBition-CM: High dose Liposomal Amphotericin for HIV related cryptococcal meningitis

      T.b.a.
    • 11:45
      S4.2d selected abstracts
  • 10:30
    S4.3 Antifungals Pipeline session

    More information will follow soon
  • S4.4 Invasive infections in Asia

    Conveners: Arunaloke Chakrabarti, India & Ruo-yu Li, China
    • 10:30
      S4.4a The unique features and challenges of yeast infections in Asia: focus on Candida tropicalis

      Yee-Chun Chen, Taiwan
    • 10:55
      S4.4b Black mycelial fungal infection with special reference to Cladophialophora bantiana - Asian perspectives

      Retno Wahyuningsih, Indonesia
    • 11:20
      S4.4c How to guard the mimic fungal infection in Asia?

      Ariya Chindamporn, Thailand
    • 11:45
      S4.4d selected abstracts
  • S4.5 EORTC New insights in the management of invasive fungal disease in haematology

    Convener: Peter Donnelly, the Netherlands
    • 10:30
      S4.5a New risk groups

      Livio Pagano, Italy
    • 10:55
      S4.5b New management strategies (EORTC study)

      Peter Donnelly, the Netherlands
    • 11:20
      S4.5c New antifungals (isavuconazole, new formulations of posaconazole, drugs in the pipeline)

      Johan Maertens, Belgium
    • 11:45
      S4.5d New guidelines (ECCMID Aspergillus, IDSA Aspergillus and ECIL2017)

      Fanny Lanternier, France
  • 10:30
    S4.6 Cases in mycology (NVMM / VIZ / Hematologists)

    More information will follow soon
  • 12:00
    Lunch break, Exhibition, Posters
  • 12:30
    Satellite symposium III

    12:30 - 13:30 hrs.
  • 13:30
    Plenary session: Clinically validation and implementation of next generation sequencing into a clinical laboratory for patient care testing

    Sean Zhang, USA
  • 14:30
    Break
  • 15:00
    Plenary session V

    Parallel session V will take place from 15:00 hrs. until 16:30 hrs. and consists of six symposia.
  • S5.1 Hot topics in Taxonomy – Can we define fungal species borders?

    Convener: June Kwon-Chung, USA
    • 15:00
      S5.1a Gene-genealogy and species boundaries in fungi with multiple look-alike/act-alike cryptic species

      David Engelthaler, USA
    • 15:25
      S5.1b What should be the ideal criteria for species delimitation in pathogenic fungi?

      John Taylor, USA
    • 15:50
      S5.1c Mitochondrial genomes and species boundaries in the genus Fusarium

      Balász Brankovics, the Netherlands
    • 16:15
      S5.1d selected abstracts
  • S5.2 Superficial dermatophytes

    Conveners: Ryoji Tsuboi, Japan & Ruoyu Li, China
    • 15:00
      S5.2a Epidemiology and clinical implication of dermatophytes and nondermatophytes in South East Asia

      Sumanas Bunyaratavej & Charussri Leeyaphan, Thailand
    • 15:25
      S5.2b Cutaneous infection by zoonotic dermatophytes: an update

      Pei-lun Sun, Taiwan
    • 15:50
      S5.2c Molecular epidemiology of dermatophytes

      Mochizuki Takashi, Japan
    • 16:15
      S5.2d New oral and topical treatments for onychomycosis

      Ryoji Tsuboi, Japan
  • S5.3 Beyond antifungal / host directed therapy

    Convener: Mihai Netea, the Netherlands
    • 15:00
      S5.3a Host-directed therapy in candidemia

      Mihai Netea, the Netherlands
    • 15:25
      S5.3b New insights in diagnosis and immunopathology of aspergillosis

      Agostinho Carvalho, Portugal
    • 15:50
      S5.3c New insights in Cryptococcus infections

      Robin May, United Kingdom
    • 16:15
      S5.3d selected abstracts
  • S5.4 Mucoralean infections

    Convener: Anna Skiada, Greece
    • 15:00
      S5.4a Managing mucormycosis: why is it so difficult? 

      Ashraf Ibrahim, USA
    • 15:25
      S5.4b Diagnostics: From histopathology and cultures to qPCR and

      Birgit Willinger, Austria
    • 15:50
      S5.4c Difficult mucomycosis cases - experience in handling

      Rajeev Soman, India
    • 16:15
      S5.4d selected abstracts
  • S5.5 From Basic Science to Patient Care

    Convener: Dieter Buchheidt (DMykG), NN (NVMy)
    • 15:00
      S5.5a Translating Antifungal Immunology into Patient Car

      Frank van de Veerdonk, the Netherlands
    • 15:30
      S5.5b Translating Mycology into Patient Care

      Oliver Kurzai, Germany
    • 16:00
      S5.5c Clinical Challenges in the Management of Invasive Fungal Infections

      Andreas Groll, Germany
  • S5.6 Fusarium WG

    Conveners: Anne van Diepeningen & Abdullah Al-Hatmi, the Netherlands
    • 15:00
      S5.6a Fusarium the trans-kingdom pathogen

      Anne van Diepeningen, the Netherlands
    • 15:25
      S5.6b Fusarium keratitis: the species and their occurrence

      Grit Walther, Germany
    • 15:50
      S5.6c Imntrinsic resistance to antifungals

      T.b.a.
    • 16:15
      S5.6d selected abstracts
  • 16:30
    Parallel session VI

    Parallel session VI will take place from 16:30 hrs. until 18:00 hrs. and consists of six symposia.
  • S6.1 Functional genomics and systems biology

    Convener: Berhard Hube, Germany
    • 16:30
      S6.1a t.b.a
    • 16:55
      S6.1b The relevance of ß subunit of F1Fo-ATP synthase to Candida albicans lethality by affecting carbon flexibility

      Shuixiu Li, China
    • 17:20
      S6.1c Candida spp. functional genomics

      Geraldine Butler, Ireland
    • 17:45
      S6.1d selected abstracts
  • S6.2 ABPA

    Convener: Ritesh Agarwal, India
    • 16:30
      S6.2a Recent advances in allergic bronchopulmonary aspergillosis complicating asthma

      Arunaloke Chakrabarti, India
    • 16:55
      S6.2b Severe asthma with fungal sensitization

      David Denning, United Kingdom
    • 17:20
      S6.2c Recent advances in allergic bronchopulmonary aspergillosis complicating cystic fibrosis

      Richard Moss, USA
    • 17:45
      S6.2d selected abstracts
  • S6.3 Tropical implantation diseases

    Convener: Flavio Queiroz-Telles, Brazil
    • 16:30
      S6.3a Management of chromomycosis: difficulties, challeges and perspectives in developping countries

      Lala Soavina Ramarozatovo, Madagascar
    • 16:55
      S6.3b The expanding cat-transmmited sporotrichosis in Brazil

      Anderson Rodrigues, Brazil
    • 17:20
      T.b.a.

      Flavio Queiroz-Telles, Brazil
    • 17:45
      S6.3d selected abstracts
  • S6.4 Aspergillus terreus frontline

    Convener: Cornelia Lass-Floerl, Austria
    • 16:30
      S6.4a The Aspergillus terreus species complex: What is new

      Jesus Guinea, Spain
    • 16:55
      S6.4b Outcome and treatment of Aspergillus terreus infections

      T.b.a.
    • 17:20
      S6.4c Amphotericin B Resistance: New insights

      Cornelia Lass-Flörl, Austria
    • 17:45
      S6.4d selected abstracts
  • S6.5 Malassezia in humans and animals

    Conveners: Jacques Guillot, France & Teun Boekhout, the Netherlands
    • 16:30
      S6.5a Analysis of Malassezia microbiota in humans and animals: does it really help us to better understand and control Malassezia-related diseases?

      Jacques Guillot, France
    • 16:55
      S6.5b T.b.a.
    • 17:20
      S6.5c The overgrowth of Malassezia spp.in canine atopic dermatitis - the reason or the result of disease?

      Bozena Worecka-Kaszak, Poland
    • 17:45
      S6.5d selected abstracts
  • S6.6 Surveillance azole resistance

    Convener: Jacques Meis, the Netherlands
    • 16:30
      S6.6a Surveillance of azole resistance in Colombia

      Patrice le Pape, France
    • 16:55
      S6.6b Surveillance and status quo of azole resistant Aspergillus in East Asia

      C.J. Wu, Taiwan
    • 17:20
      S6.6c Aspergillus Azole resistance surveillance in Brazi

      t.b.a.
    • 17:45
      S6.6d The present status and surveillance of azole resistance in North America

      Elisabeth Berkov, USA
  • 18:00
    Wine, cheese & posters
  • 19:00
    Young ISHAM Evening
  • 20:00
    Spanish Speaking ISHAM/ECMM/GAFFI meeting Middle- and Latin America (Mexico, Colombia, Chile, Argentina, Ecuador, Uruguay, Venezuela…)

    All ISHAM participants from the respective countries targeted by these outreach efforts would receive personal invitations to the respective evenings.